IRCT20200623047902N31尚未招募Unknown
Bioequivalence study of Phenazopyridine 100mg tablet manufactured by Ronak Pharm versus originator brand in healthy volunteers in the fasted condition
Ronak Pharm company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to Phenazopyridine
研究者
相似试验
招募中
Unknown
Bioequivalence study of phenazopyridine hydrochloride 100 mg tablet---.IRCT20230222057495N11Mehr Darou Pharmaceutical Company24
招募中
Unknown
Investigating bioequivalence of Pentoprazole capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N14Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of aripiprazole 5 mg tablet---.IRCT20230222057495N6Chemidarou Pharmaceutical Company24
尚未招募
不适用
Study of absorption and elimination rate of Pirfenidone 200-mg Tablets in comparison with Pirfenidone brand Tablets (Pirfenex®).Bioequivalence study.IRCT20200407046981N30Modava pharmaceutical company24
已完成
不适用
Comparative bioequivalence study of the Pazopanib 200-mgTablets manufactured by Noavaran Daroui Kimia CompanyIRCT20130313012810N13KIMIA Noavaran Daroui24